Periodontal Therapeutic Market Research Report – Forecast to 2027

Periodontal Therapeutic Market Research Report: By Type (Chronic Periodontitis Aggressive Periodontitis and Necrotizing Periodontal), by Treatment (Systematic Antibiotics and Others), by End-Users (Dental Hospital and Others)— Forecast Till 2027

ID: MRFR/Pharma/5100-HCR | February 2021 | Region: Global | 100 pages

Periodontal Therapeutic Market Scenario


The periodontal therapeutic market size is expected to grow significantly over the forecast period. It is estimated that the global periodontal therapeutic market is expected to register a CAGR of ~ 9.2 % during the forecast period from 2018 to 2023.

Periodontal is a chronic inflammatory disease of the periodontium. It is the main cause of tooth loss and is considered one of the two biggest threats to oral health. Periodontal disease is prevalent in both developed and developing countries and affects about 20 to 50% of the global population. Hence periodontal therapies are used to treat periodontal disease. It can be treated by either surgical or non-surgical treatment. Various factors such as smoking, poor oral hygiene, hormonal changes in females, diabetes mellitus, stress are responsible for periodontal diseases. These factors are also driving for the growth of the periodontal therapeutic market. According to world health organization, gingival bleeding is highly prevalent among adult populations in all regions of the world; advanced disease with deep periodontal pockets (6 mm or more) affects 10 to 15% of adults worldwide.        

Increasing aging population has increased incidences of periodontal diseases, which are boosting the periodontal therapeutics market globally.

However, people have a very casual approach to oral hygiene, which can lead to a negative impact on the growth of the market in the future.  

Segmentation

The global periodontal therapeutic market has been segmented on basis of type, treatment, and end-users. On basis of type, the market is segmented into three types such as gingivitis, chronic periodontitis, aggressive periodontitis, and necrotizing periodontal disease. Based on treatment, the market is segmented into two segments such as systematic antibiotics and local antibiotics. Systematic antibiotics are further sub-segmented into doxycycline, minocycline, metronidazole, and others. Local antibiotics are further segmented into arestin, chlorhexidine, and others. On basis of end-user market is further is segmented into dental clinics and hospitals. 

Key players


  • Fibrocell Sciences, Inc

  • Tolmar Inc

  • Eli Lilly & Company

  • Align Technology Inc

  • Dentsply International

  • 3M-ESPE

  • Ultradent Products Inc

  • Nobel Biocare Holdings AG

  • Glidewell Laboratories, Inc

  • Orapharma

  • Kaken Pharmaceutical

  • Valeant Pharmaceuticals Int. Inc

  • Den-Mat Holdings

  • Mallinckrodt Pharmaceuticals

  • Purdue Pharma L.P.

  • Teva Pharmaceutical Industries Limited.


Regional Market Summary

Global Periodontal Therapeutic Market Share (%), by Region, 2018

Periodontal Therapeutic Market Share

Source: World Health Organization (WHO), Centre for Disease Control and Prevention (CDC)

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The periodontal therapeutic market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European periodontal therapeutic market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, UK, Italy, Spain, and the rest of Western Europe. The periodontal therapeutic market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The periodontal therapeutic market in the Middle East and Africa has been segmented into the Middle East and Africa.

On the basis of region, the market is segmented into North America, Europe, Asia-Pacific, and the Middle East and Africa. The North American market is anticipated to dominate the periodontal therapeutic market due to rising prevalence of periodontal diseases among the geriatric population.  According to recent findings from the Centre for Disease Control and Prevention (CDC), half of Americans aged 30 or older have periodontitis, the more advanced form of periodontal disease. This equals approximately 64.7 million Americans are suffering from periodontal diseases.  

Europe is anticipated to drive the growth of the periodontal therapeutic market in upcoming years due to increasing incidences of an aging population suffering from diabetes, sedentary lifestyle and efficient reimbursement scenario.

Asia-Pacific is projected to register robust growth in the future due to large patient population and growing healthcare infrastructure and expenditure.

The Middle East and Africa is expected to account for the lowest market share in the global periodontal therapeutic market due to the lack of advanced technology and poor medical facilities in developing economies in this region.

Global Periodontal Therapeutic Market, by Types



  • Gingivitis

  • Chronic periodontitis

  • Aggressive periodontitis

  • Necrotizing periodontal disease



Global Periodontal Therapeutic Market, by Treatment



  • Systematic Antibiotics

  • Doxycycline

  • Minocycline

  • Metronidazole

  • Others

  • Local Antibiotics

  • Arestin

  • Chlorhexidine

  • Others



Global Periodontal Therapeutic Market, by End-Users



  • Dental clinics

  • Hospital



Global Periodontal Therapeutic Market, by Region



  • Americas



  • North America

  • US

  • Canada

  • South America



  • Europe



  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Western Europe

  • Eastern Europe



  • Asia-Pacific



  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific



  • Middle East & Africa



  • Middle East

  • Africa



 Intended Audience



  • Dental equipment manufacturers



  • Vendors and distributors of dental systems



  • Research and Development (R&D) companies



  • Raw material suppliers



  • General dentists and cosmetic dentists



  • Government Research Institutes



  • Academic institutes and universities




Report Scope:
Report Attribute/Metric Details
  Market Size   Significant Value
  CAGR   2018-2023: ~ 9.2 %
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Basis Of Type, Treatment, and End-Users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Fibrocell Sciences, Inc, Tolmar Inc, Eli Lilly & Company, Align Technology Inc., Dentsply International, 3M-ESPE, Ultradent Products Inc, Nobel Biocare Holdings AG, Glidewell Laboratories, Inc, Orapharma, Kaken Pharmaceutical, Valeant Pharmaceuticals Int. Inc, Den-Mat Holdings, Mallinckrodt Pharmaceuticals, Purdue Pharma L.P., Teva Pharmaceutical Industries Limited.
  Key Market Opportunities   Increasing aging population has increased incidences of periodontal diseases
  Key Market Drivers   Smoking, poor oral hygiene, hormonal changes in females, diabetes mellitus, stress are responsible for periodontal diseases


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :


Periodontal Therapeutic Market is projected to grow at a 9.2% CAGR between 2018-2027.

North America is projected to command the largest share in Periodontal Therapeutic Market.

End use industries of Periodontal Therapeutic Market include hospitals and dental clinics.

Rising incidences of periodontal diseases is boosting market growth.

Casual approach towards oral hygiene may limit market growth.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Periodontal Therapeutic Market, by Types

6.1 Introduction

6.2 Gingivitis

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3 Chronic periodontitis

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4 Aggressive periodontitis

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5 Necrotizing periodontal

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 7. Global Periodontal Therapeutic Market, by Treatment

7.1 Introduction

7.2 Systematic Antibiotics

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.2.1 Doxycycline

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.2.2 Minocycline

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.2.3 Metronidazole

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.2.4 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3 Local Antibiotics

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3.1 Arestin

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3.2 Chlorhexidine

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3.3 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 8. Global Periodontal Therapeutic Market, by End-Users

8.1 Introduction

8.2 Dental Clinic

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–202

8.3 Hospitals

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.4 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 9. Global Periodontal Therapeutic Market, by Region

9.1 Introduction

9.2 America

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Fibrocell Sciences, Inc

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Tolmar Inc

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Eli Lilly & Company

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Align Technology Inc.

11.4.1 Company Overview

11.4.2 Product Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Dentsply International

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 3M-ESPE

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Ultradent Products Inc

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11. 8 Nobel Biocare Holdings AG

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11. 9 Glidewell Laboratories, Inc

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Orapharma

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Kaken Pharmaceutical

11.12.1 Overview

11.12.2 Product Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.12 Valeant Pharmaceuticals Int. Inc

11.12.1 Overview

11.12.2 Product Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11. 13 Den-Mat Holdings

11. 13.1Overview

11. 13.2Product Overview

11. 13.3Financials

11. 13.4Key Developments

11. 13.5SWOT Analysis

11. 14 Mallinckrodt Pharmaceuticals

11. 14.1Overview

11. 14.2Product Overview

11. 14.3Financials

11. 14.4Key Developments

11. 14.5SWOT Analysis

11. 15 Purdue Pharma L.P

11. 15.1Overview

11. 15.2Product Overview

11. 15.3Financials

11. 15.4Key Developments

11. 15.5SWOT Analysis

11. 16 Teva Pharmaceutical Industries Limited

11.16.1Overview

11.16.2Product Overview

11.16.3Financials

11.16.4Key Developments

11.16.5SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Global Periodontal Therapeutic Industry

Chapter 13. Appendix


LIST OF TABLES

Table 1 Global Periodontal Therapeutic Market Synopsis, 2020–2027

Table 2 Global Periodontal Therapeutic Market Estimates and Forecast, 2020–2027 (USD Million)

Table 3 Global Periodontal Therapeutic Market, by Types, 2020–2027 (USD Million)

Table 4 Global Periodontal Therapeutic Market, by Treatment, 2020–2027 (USD Million)

Table 5 Global Periodontal Therapeutic Market, by End-User, 2020–2027 (USD Million)

Table 6 Global Periodontal Therapeutic Market, by Region, 2020–2027(USD Million)

Table 7 North America: Periodontal Therapeutic Market, by Types, 2020–2027 (USD Million)

Table 8 North America: Periodontal Therapeutic Market, by Treatment, 2020–2027 (USD Million)

Table 9 North America: Periodontal Therapeutic Market, by End-User, 2020–2027 (USD Million)

Table 10 North America: Periodontal Therapeutic Market, by Region, 2020–2027 (USD Million)

Table 11 US: Periodontal Therapeutic Market, by Types, 2020–2027 (USD Million)

Table 12 US: Periodontal Therapeutic Market, by Treatment, 2020–2027 (USD Million)

Table 13 US: Periodontal Therapeutic Market, by End-User, 2020–2027 (USD Million)

Table 14 US: Periodontal Therapeutic Market, by Region, 2020–2027 (USD Million)

Table 15 Canada: Periodontal Therapeutic Market, by Types, 2020–2027 (USD Million)

Table 16 Canada: Periodontal Therapeutic Market, by Treatment, 2020–2027 (USD Million)

Table 17 Canada: Periodontal Therapeutic Market, by End-User, 2020–2027 (USD Million)

Table 18 Canada: Periodontal Therapeutic Market, by Region, 2020–2027 (USD Million)

Table 19 South America: Periodontal Therapeutic Market, by Types, 2020–2027 (USD Million)

Table 20 South America: Periodontal Therapeutic Market, by Treatment, 2020–2027 (USD Million)

Table 21 South America: Periodontal Therapeutic Market, by End-User, 2020–2027 (USD Million)

Table 22 South America: Periodontal Therapeutic Market, by Region, 2020–2027 (USD Million)

Table 23 Europe: Periodontal Therapeutic Market, by Types, 2020–2027 (USD Million)

Table 24 Europe: Periodontal Therapeutic Market, by Treatment, 2020–2027 (USD Million)

Table 25 Europe: Periodontal Therapeutic Market, by End-User, 2020–2027 (USD Million)

Table 26 Europe: Periodontal Therapeutic Market, by Region, 2020–2027 (USD Million)

Table 27 Western Europe: Periodontal Therapeutic Market, by Types, 2020–2027 (USD Million)

Table 28 Western Europe: Periodontal Therapeutic Market, by Treatment, 2020–2027 (USD Million)

Table 29 Western Europe: Periodontal Therapeutic Market, by End-User, 2020–2027 (USD Million)

Table 30 Western Europe: Periodontal Therapeutic Market, by Region, 2020–2027 (USD Million)

Table 31 Eastern Europe: Periodontal Therapeutic Market, by Types, 2020–2027 (USD Million)

Table 32 Eastern Europe: Periodontal Therapeutic Market, by Treatment, 2020–2027 (USD Million)

Table 33 Eastern Europe: Periodontal Therapeutic Market, by End-User, 2020–2027 (USD Million)

Table 34 Eastern Europe: Periodontal Therapeutic Market, by Region, 2020–2027 (USD Million)

Table 35 Asia-Pacific: Periodontal Therapeutic Market, by Types, 2020–2027 (USD Million)

Table 36 Asia-Pacific: Periodontal Therapeutic Market, by Treatment, 2020–2027 (USD Million)

Table 37 Asia-Pacific: Periodontal Therapeutic Market, by End-User, 2020–2027 (USD Million)

Table 38 Asia-Pacific: Periodontal Therapeutic Market, by Region, 2020–2027 (USD Million)

Table 39 Middle East & Africa: Periodontal Therapeutic Market, by Types, 2020–2027 (USD Million)

Table 40 Middle East & Africa: Periodontal Therapeutic Market, by Treatment, 2020–2027 (USD Million)

Table 41 Middle East & Africa: Periodontal Therapeutic Market, by End-User, 2020–2027 (USD Million)

Table 42 Middle East & Africa: Periodontal Therapeutic Market, by Region, 2020–2027 (USD Million)



LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Periodontal Therapeutic Market

Figure 3 Segmentation Market Dynamics for Global Periodontal Therapeutic Market

Figure 4 Global Periodontal Therapeutic Market Share, by Types, 2020(%)

Figure 5 Global Periodontal Therapeutic Market Share, by Treatment, 2020(%)

Figure 6 Global Periodontal Therapeutic Market Share, by End-User, 2020(%)

Figure 7 Global Periodontal Therapeutic Market Share, by Region, 2020(%)

Figure 8 North America: Periodontal Therapeutic Market Share, by Country, 2020(%)

Figure 9 Europe: Periodontal Therapeutic Market Share, by Country, 2020(%)

Figure 10 Asia-Pacific: Periodontal Therapeutic Market Share, by Country, 2020(%)

Figure 11 Middle East & Africa: Periodontal Therapeutic Market Share, by Country, 2020(%)

Figure 12 Global Periodontal Therapeutic Market: Company Share Analysis, 2020(%)

Figure 13 Fibrocell Sciences, Inc: Key Financials

Figure 14 Fibrocell Sciences, Inc: Segmental Revenue

Figure 15 Fibrocell Sciences, Inc: Geographical Revenue

Figure 16 Tolmar Inc: Key Financials

Figure 17 Tolmar Inc: Segmental Revenue

Figure 18 Tolmar Inc: Geographical Revenue

Figure 19 Eli Lilly & Company: Key Financials

Figure 20 Eli Lilly & Company: Segmental Revenue

Figure 21 Eli Lilly & Company: Geographical Revenue

Figure 22 Align Technology Inc: Key Financials

Figure 23 Align Technology Inc: Segmental Revenue

Figure 24 Align Technology Inc: Geographical Revenue

Figure 25 DENTSPLY INTERNATIONAL.: Key Financials

Figure 26 DENTSPLY INTERNATIONAL.: Segmental Revenue

Figure 27 DENTSPLY INTERNATIONAL.: Geographical Revenue

Figure 28 3M-ESPE.: Key Financials

Figure 29 3M-ESPE.: Segmental Revenue

Figure 30 3M-ESPE.: Geographical Revenue

Figure 31 Ultradent Products Inc: Key Financials

Figure 32 Ultradent Products Inc: Segmental Revenue

Figure 33 Ultradent Products Inc: Geographical Revenue

Figure 34 Nobel Biocare Holdings AG: Key Financials

Figure 35 Nobel Biocare Holdings AG: Segmental Revenue

Figure 36 Nobel Biocare Holdings AG: Geographical Revenue

Figure 37 Glidewell Laboratories, Inc: Key Financials

Figure 38 Glidewell Laboratories, Inc: Segmental Revenue

Figure 39 Glidewell Laboratories, Inc: Geographical Revenue

Figure 40 Orapharma: Key Financials

Figure 41 Orapharma: Segmental Revenue

Figure 42 Orapharma: Geographical Revenue

Figure 43 Kaken Pharmaceutical: Key Financials

Figure 44 Kaken Pharmaceutical: Segmental Revenue

Figure 45 Kaken Pharmaceutical: Geographical Revenue

Figure 46 Valeant Pharmaceuticals Int. Inc: Key Financials

Figure 47 Valeant Pharmaceuticals Int. Inc: Segmental Revenue

Figure 48 Valeant Pharmaceuticals Int. Inc: Geographical Revenue

Figure 49 Den-Mat Holdings.: Key Financials

Figure 50 Den-Mat Holdings.: Segmental Revenue

Figure 51 Den-Mat Holdings.: Geographical Revenue

Figure 52 Mallinckrodt Pharmaceuticals: Key Financials

Figure 53 Mallinckrodt Pharmaceuticals: Segmental Revenue

Figure 54 Mallinckrodt Pharmaceuticals: Geographical Revenue

Figure 55 Purdue Pharma L.P: Key Financials

Figure 56 Purdue Pharma L.P: Segmental Revenue

Figure 57 Purdue Pharma L.P: Geographical Revenue

Figure 58 Teva Pharmaceutical Industries Limited: Key Financials

Figure 59 Teva Pharmaceutical Industries Limited: Segmental Revenue

Figure 60 Teva Pharmaceutical Industries Limited: Geographical Revenue